Dr. Leen Senten SRL
Dr. Leen Senten reported total assets of €1.58m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026).
By total assets for 2025, Dr. Leen Senten ranks among the 2,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Leen Senten shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Leen Senten's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 23 Jul 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 24 Aug 2022
Dr. Leen Senten's financial analysis
- Solvency80.2%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Leen Senten
Dr. Leen Senten's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.580.502
- VAT number
- BE0896580502
- Peppol
- Registered · 0208:0896580502 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Mar 2008
- Registered office
- 2970 Schilde
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Leen Senten (SRL) has been based in Schilde since 2008, active in: medical specialists activities. For 2025, it reports a net profit of 206,499 € and equity of €1.27m; its revenue is not published. Its solvency stands at 80.2%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Leen Senten
Companies in the same business, of comparable size and area, outside its group.
- Verem Antwerp · balance sheet €1.58m
- WL-Invest Business and other management consultancy activities Geel · balance sheet €1.59m
- Terestria Service activities incidental to land transportation Knokke-Heist · balance sheet €1.59m
- Jomic-Renting Ghent · balance sheet €1.59m
- Laffimmo Lasne · balance sheet €1.58m
- Sandy Wood Woluwe-Saint-Pierre · balance sheet €1.58m
- Dr. Mulkens Tom Antwerp · balance sheet €1.58m
Frequently asked questions about Dr. Leen Senten
What is the revenue of Dr. Leen Senten?
Dr. Leen Senten files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Leen Senten?
In Belgium, the VAT number is the company number prefixed with BE: BE0896580502 for Dr. Leen Senten, if the company is VAT-registered. Its company number (CBE) is 0896.580.502.
Where is the registered office of Dr. Leen Senten?
According to the CBE register, the registered office of Dr. Leen Senten is in 2970 Schilde.
What is the equity of Dr. Leen Senten?
At the close of the 2025 financial year, the equity of Dr. Leen Senten amounts to 1,270,511 €, a solvency of 80.2% of total assets.
Who manages Dr. Leen Senten?
The register lists 1 active mandates at Dr. Leen Senten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Leen Senten within its sector?
By total assets for 2025, Dr. Leen Senten ranks among the 2,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. Leen Senten
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →